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Abstract
 
Studying the influence of chemokine receptors (CCRs) on monocyte fate may reveal informa-
tion about which subpopulations of monocytes convert to dendritic cells (DCs) and the migration
pathways that they use. First, we examined whether prominent CCRs on different monocyte
subsets, CCR2 or CX
 
3
 
CR1, mediated migration events upstream of the accumulation of
monocyte-derived DCs in lymph nodes (LNs). Monocytes were labeled and traced by uptake of
latex microspheres in skin. Unexpectedly, neither CCR2 nor CX
 
3
 
CR1 were required. However,
absence of CCR2 led to an increased labeling of the minor Gr-1
 
int
 
 monocyte population, and
the number of latex
 

 
 DCs that emigrated to LNs was correspondingly increased. Characteriza-
tion of Gr-1
 
int
 
 monocytes revealed that they selectively expressed CCR7 and CCR8 mRNA in
blood. CCR7 and CCR8 pathways were used by monocyte-derived DCs during mobilization
from skin to LNs. The role of CCR8 in emigration from tissues also applied to human mono-
cyte-derived cells in a model of transendothelial trafficking. Collectively, the data suggest that
Gr-1
 
int
 
 monocytes may be most disposed to become a lymphatic-migrating DCs. When these
monocyte-derived DCs exit skin to emigrate to LNs, they use not only CCR7 but also CCR8,
which was not previously recognized to participate in migration to LNs.
Key words: chemotaxis • endothelium • inflammation • lymphatic system • macrophage
 
Introduction
 
Monocytes differentiate into either macrophages or migra-
tory LN-homing DCs in vivo (1). Little is known about
the molecular events that guide the “decision” of a mono-
cyte to become a macrophage or a migratory DC. Like-
wise, we know very little about the molecules that medi-
ate the migration of monocyte-derived DCs from blood,
through tissue, to LNs. Different chemokine receptor (CCR)
profiles are known to characterize different subsets of mono-
cytes; tracing the roles and expression of CCRs can lend
information about the type of monocyte that becomes a
DC versus a macrophage.
In both mouse and human, there are two major subsets
of monocytes. They are distinguished in part by CCR ex-
pression patterns (2–4), and in mouse by differential levels
of cell surface Gr-1 (4). “Classical” monocytes in both species
are CCR2
 

 
, whereas another population of monocytes in
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both species expresses CCR2 only at low levels and charac-
teristically show higher levels of surface CX
 
3
 
CR1 than the
other monocytes (3, 4). A consensus does not exist on a
possible lineage relationship between these subsets, but
some evidence suggests that CCR2
 

 
 monocytes are the
precursors for CCR2
 

 
 monocytes (5), and that these two
phenotypes are separated by a third “transitional” subset
(5). The transitional monocyte subset has not been well
studied in mice, but some analysis of this population
has been done using human monocytes (3, 6). They are
CD64
 

 
CD14
 

 
CD16
 

 
 and express CCR2. Interestingly,
they tend to express the whole range of CCRs that other-
wise distinguish the two major subsets, in addition to unique
expression of other CCRs (3). Although very low in fre-
quency in blood, their wider range of CCR expression
may make them the most flexible population of monocytes
for recruitment to different chemokine signals.
In this paper, we characterized the roles of several CCRs
in mediating migration events that were especially relevant
to the appearance of monocyte-derived DCs in LNs via
lymphatics. CCR2 is a key mediator of monocyte migra-
tion to peritoneal cavity (7, 8) and into LNs via high en-
dothelial venule (9) during robust inflammatory reactions
evoked by pathogen-derived components, but such com-
ponents can prevent the differentiation of monocytes into
lymph-homing DCs (10). The trafficking of some APCs
also relies on CCR2 (11–14), although it is not clear that
these APCs derive from monocytes or another CCR2
 

 
precursor. Our data indicate that CCR2 is unexpectedly
not essential for any of the migratory events that lead to the
accumulation of monocyte-derived DCs in LNs from skin,
as assessed in CCR2
 

 
 mice, under the relatively mild in-
flammatory conditions studied. CX
 
3
 
CR1, studied using
CX
 
3
 
CR1
 
gfp
 
 knockin mice (4, 15), was also dispensable for
the accumulation of monocytic DC precursors in skin or
later in LNs. Analysis in these knockout/knockin mouse
strains pointed to “transition state” (Gr-1
 
int
 
) monocytes as
likely being the population monocytes that most readily
convert to lymph-homing DCs. In blood, Gr-1
 
int
 
 mono-
cytes were already oriented for differentiation to DCs, as
they selectively expressed mRNA for CCR7 and CCR8,
two CCRs that we show are required for emigration of
monocyte-derived DCs from skin to LNs. Thus, this work
unravels new aspects of the migratory pathways used by
monocyte-derived DCs during recruitment from blood
into skin and subsequent mobilization to LNs.
 
Materials and Methods
 
Mice. 
 
All procedures described herein involving mice were
approved by the Institutional Animal Care and Use Committee at
Mt. Sinai School of Medicine. CCR8
 

 
 mice (16) were back-
crossed 10 times onto the C57BL/6 strain using breeders from
Charles River Laboratories. Analyses were conducted in these or
C57BL/6 WT mice (Charles River Laboratories or Jackson Im-
munoResearch Laboratories), CX
 
3
 
CR1
 
gfp/
 

 
 (15), CX
 
3
 
CR1
 
gfp/gfp
 
(15), CCR2
 

 
 (7, 8), or 
 
plt/plt
 
 mice (17, 18) all on a C57BL/6
background.
 
Quantification of Monocyte-derived DC Migration to LNs.
 
FITC-labeled polystyrene microspheres (1-
 

 
m diameter; Poly-
sciences) or 1-
 

 
m red fluorescent microspheres (T-8883; Molec-
ular Probes) were diluted to 0.1% (wt/vol), and 10 
 

 
l was in-
jected into the shaved back skin overlying the region of the
brachial LN of anesthetized CCR8
 

 
 or CCR8
 

 
 C57BL/6
mice. Two injections were made on each side. 3 d later, brachial
LNs were pooled from each injected mouse and digested with
collagenase D free of tryptic activity (Boehringer) for 30 min.
Single cell suspensions were generated by pressing LN cells
through a 70-
 

 
M cell strainer and were stained with conjugated
mAbs from BD Biosciences. For each mouse, the whole LN
preparation was analyzed by flow cytometry, and the number of
cells bearing two or more fluorescent particles was quantified.
Cells bearing only one microsphere/cell are not clearly of mono-
cyte origin, in contrast with the more phagocytic cells, and their
accumulation in LNs does not correlate with that of monocyte-
derived cells (1).
 
Dermal Cell Suspensions.
 
Areas of the dermis where beads
were injected were visible due to the focal location of the bright
fluorescent beads in the skin. These areas were excised with
dissecting scissors and digested with 1.8 mg/ml of LPS-free
Blendzyme Liberase III obtained from Roche diluted in RPMI
1640 for 30 min. EDTA was added, and cells were passed through
a 70-
 

 
m strainer before flow cytometric staining.
 
Immunostaining. 
 
Frozen section of WT skin and LNs were
fixed in acetone, stained with rat anti-CCL1 mAb (R&D Sys-
tems), and detected with Cy3-conjugated anti–rat IgG (Jackson
ImmunoResearch Laboratories). A polyclonal rabbit anti–LYVE-1
Ab (Upstate Biotechnology) was used to identify lymphatic ves-
sels detected with FITC-conjugated anti–rabbit IgG (Jackson Im-
munoResearch Laboratories).
 
Mouse Blood Monocytes. 
 
Whole blood was subjected to red
cell lysis using Pharmlyse (BD Biosciences) and washed twice in
DMEM containing 5 mM EDTA and 0.5% BSA. Cells were in-
cubated in HBSS containing 0.02% NaN
 
3
 
 and 2 mM EDTA, 2%
FBS, 1% normal mouse serum, and 20 
 

 
g/ml CD16/CD32 Fc
receptor–blocking mAb (BD Biosciences). Four-color staining
for flow cytometric analysis was conducted using combinations of
the following mAbs. All mAbs were from BD Biosciences, ex-
cept where otherwise indicated: F4/80 (Serotec), CD115 (eBio-
science), Gr-1, IgG2a isotype control, mouse IgG1, rat IgG2a, or
hamster IgG. Clodronate was a gift from Roche and was incor-
porated into liposomes as described previously (19). In some
mice, blood monocytes were eliminated with these liposomes by
i.v. injection of 0.2 ml into the lateral tail vein (5). Control lipo-
somes that incorporated PBS instead of clodronate were used, but
without affecting total monocytes or subpopulations.
 
Real-Time PCR.
 
Monocytes stained for F4/80, CD115, and
Gr-1 were subjected to flow cytometric cell sorting to separate
Gr-1
 
hi
 
, Gr-1
 
int
 
, and Gr-1
 
lo
 
 populations, all F4/80
 

 
CD115
 

 
.
RNA was extracted, followed by DNase treatment. cDNA was
prepared from these samples using random primers (Invitrogen)
and Sensiscript RT kit (QIAGEN). These cDNA were used for
real-time PCR to quantify ubiquitin, sense primer 5
 

 
-TGGC-
TATTAATTATTCGGTCTGCAT-3
 

 
, antisense primer 5
 

 
-
GCAAGTGGCTAGAGTGCAGAGTAA-3
 

 
; CCR2, sense
primer 5
 

 
-GTTACCTCAGTTCATCCA-3
 

 
, antisense primer
5
 

 
-CAAGGCTCACCATCATCGTAGTC-3
 

 
; CX
 
3
 
CR1, sense
primer 5
 

 
-TGTCCACCTCCTTCCCTGAA-3
 

 
, antisense
primer 5
 

 
-TCGCCCAAATAACAGGCC-3
 

 
; CCR7, sense
primer 5
 

 
-CACGCTGAGATGCTCACTGG-3
 

 
, antisense
primer 5
 

 
-CCATCTGGGCCACTTGGA-3
 

 
; and CCR8 ex-
 Qu et al.
 
1233
 
pression, sense primer 5
 

 
-TGACCGACTACTACCCTGATT-
TCTT-3
 

 
, antisense primer 5
 

 
-GCTGCCCCTGAGGAGGAA-
3
 

 
. The cDNA was amplified in the presence of QuantiTech
SYBR green PCR master mix oligonucleotides and HotStarTaq
DNA Polymerase (QIAGEN) in a Roche Lightcycler. The rela-
tive expression of each CCR was calculated against the relative
abundance of cDNA encoding for ubiquitin. Using this method,
relative differences in copy number for a given cDNA can be dis-
cerned, but comparisons between different cDNAs (i.e., relative
expression of CCR2 vs. CCR8) are not valid.
 
In Vitro Culture of Monocytes Retrieved from Peritoneal Lavage
(10). 
 
Mice received 1 ml of 4% thioglycollate i.p., and 0.5 ml
of FITC-labeled microspheres (0.02% wt/vol; Polysciences) 18 h
later. Cells retrieved from peritoneal lavage were sorted using the
same protocol as for blood monocytes and cultured for 2 d in
growth medium supplemented with conditioned medium from
GM-CSF–producing J588L cells. Additions to the growth me-
dium in some samples included neutralizing goat anti–mouse
CCL1 polyclonal Ab (R&D Systems) or goat anti–mouse CCL19
polyclonal Ab (R&D Systems) at 5 or 10 
 

 
g/ml.
 
Allostimulation. 
 
For allostimulation assays, splenic BALB/c T
cells were isolated by negative selection to remove MHC II posi-
tive cells using Dynal magnetic beads and removal of additional
macrophages by adherence. Graded doses of test antigen-present-
ing cells were cultured with 10
 
5
 
 T cells per microtiter well. 4 d
later, 4 
 

 
Ci/ml [
 
3
 
H]thymidine was added. Cells were harvested,
and incorporated [
 
3
 
H]thymidine was quantified 15 h after addi-
tion of this tracer.
 
Human Monocyte Cultures and Reverse Transmigration Assay.
 
Reverse-transmigrated and monocyte-derived cells were studied
using previously described methods (20, 21). Second passage hu-
man umbilical vein endothelial cells were cultured on bovine type
I collagen gels. Blood was drawn according to guidelines approved
by the Internal Review Board of Mt. Sinai School of Medicine.
PBMCs were applied to the endothelium in some experiments in
the presence of anti-CCR8 mAb or IgG1 isotype control mAb
obtained from R&D Systems, incubated for 1.5 h, washed thor-
oughly in medium to remove nonmigrated cells from above the
endothelium, and continued in culture for 48 h. Monocytes mi-
grated across the endothelium during the 1.5-h incubation (22).
Neutralizing or control mAbs were included in the medium (5
 

 
g/ml each) and were applied to the cultures after the wash at
1.5 h. Neutralizing mouse anti–human CCR8 mAbs 3B10, 2D10,
and 5B11 were generated as described previously (23, 24).
For quantification of reverse transmigration, samples were fixed
at 1.5 h or at 48 h. Differential interference contrast was used to
quantify the number of monocyte-derived cells that were beneath
the endothelium in at least five high-power fields per sample. Each
experiment included three to six replicates per parameter tested.
Percent of reverse transmigrated cells was calculated as the percent
decrease in the number of monocyte-derived cells beneath the en-
dothelial monolayer at 48 h relative to the number present at 1.5 h.
Preparation of CD16
 

 
 monocytes and their culture in TGF
 

 
1 to
induce CD16
 

 
 cells was conducted as described previously (25).
 
Immunoblots, PCR, and Flow Cytometry to Detect Human
CCR8. 
 
For flow cytometry, monocyte-derived cells were
stained with anti–human CCR8 mAb 3B10 (23, 24), detected
with biotinylated anti–mouse Ab (Jackson ImmunoResearch
Laboratories), followed by streptavidin allophycocyanin (Caltag).
For immunoblots, plasma membrane-enriched microsomes from
1–3 
 

 
 10
 
6
 
 purified cells were prepared, subjected to SDS-PAGE,
and transferred to nitrocellulose membranes. After blocking with
5% milk, the membrane was incubated overnight with 2 
 

 
g/ml
anti-CCR8 mAbs 2D10 or 3B10, or anti–
 

 
-actin mAb (Santa
Cruz Biotechnology, Inc.) and detected with horseradish peroxi-
dase–conjugated anti–mouse or anti–rat IgG, respectively, and
ECL substrate (Amersham Biosciences).
Cultured human skin explants served as a source of human
skin DCs and their CD14
 

 
 precursors (26). Emigrated cells col-
lected 2 d after onset of explant culture were incubated with anti-
CD14 magnetic microbeads (Miltenyi Biotec) to positively select
CD14
 

 
 emigres. CD14
 

 
 DCs were selected and purified from
skin T cells using anti–HLA-DR mAb-coupled magnetic beads
(Dynal). For PCR, synthesis of cDNA from purified monocyte
mRNA was performed using random primers. Amplification was
for 30 cycles with annealing temperature of 54
 

 
C for 45 s and ex-
tension at 72
 

 
C for 45 s. Primers to amplify human CCR8
cDNA were 5
 

 
-TGGCCCTGTCTGACCTGCTTT-3
 

 
 and 5
 

 
-
GGCATAAGTCAGCTGTTGGCT-3
 

 
, which amplified a 613-
bp product. Amplification of GAPDH used primers 5
 

 
-ACCA-
CAGTCCATGCCATCAC-3
 

 
 and 5-TCCACCACCCTGT-
TGCTGTA-3, which amplifies a 412-bp product.
Statistics. Statistical analysis was conducted using JMP soft-
ware and Prizm software. Statistical tests were performed using All
Pairs Tukey-Kramer analysis and/or two-tailed Student’s t test.
Online Supplemental Material. Fig. S1 illustrates that deple-
tion of peripheral blood monocytes eliminates the appearance of
latex (LX)-bearing cells in the draining lymph node. Fig. S2 de-
picts the use of CD115 and F4/80 co-staining to identify mouse
blood monocytes, and their further division into three subsets
distinguished by differing levels of Gr-1. Fig. S3 shows PCR
products for CCR8 and GAPDH in human blood monocyte
populations before and after coculture with endothelium. Online
supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20032152/DC1.
Results
Tracing Monocytes That Convert to Phagocytic Lymph-homing
DCs Using CX3CR1 Knockin Mice. An excellent means to
track monocyte subsets is through the use of mice bearing a
GFP reporter knocked-in to the CX3CR1 locus (4, 9, 15).
Gr-1hi monocytes express lower levels of GFP (GFPmed) than
Gr-1lo monocytes (GFPhi; reference 4), corresponding to the
somewhat higher levels of CX3CR1 in this monocyte popu-
lation. CX3CR1gfp mouse blood also contains a small Gr-1int
population of monocytes (10% of total monocytes), as an-
ticipated from previous work (5). The mean fluorescence of
GFP in this population was intermediate between the Gr-1hi
and Gr-1lo populations (Fig. 1, A and B).
To trace monocytes into skin and later into LNs, red flu-
orescent microspheres were injected i.c. into the shaved
back skin of mice (1). 14 h after bead injection into the skin
of CX3CR1gfp/ or CX3CR1-deficient (gfp/gfp) mice, the
vast majority of phagocytic, bead-bearing monocytes had a
uniform size and GFP intensity that overlapped with Gr-1hi
and Gr-1int monocytes (Fig. 1, B and C). Very few, if any
GFPhi Gr-1lo monocytes were apparent, consistent with the
inability of this subset to respond to inflammatory chemo-
kines (4). A minority (25%) of bead-bearing cells were
GFP (Fig. 1 C). These may be derived from resident mac-
rophages, which are generally GFP in CX3CR1 knockin
mice (15), or they may be other types of phagocytes like
Chemokine Pathways Used by Monocyte-derived DCs1234
neutrophils, or even dying cells that have leaked GFP.
Overall, these data indicate that tracer beads are engulfed
by monocytes of two phenotypes, Gr-1hi and Gr-1int, and
indicate that monocyte-derived DCs that traffic through
skin before mobilizing to LN do not derive from CCR2
Gr-1lo monocytes under the conditions examined.
In the draining LN, analyzed at day 2 when most LX cells
appear in LNs, there were no differences in the number of
bead-bearing monocyte-derived DCs in CX3CR1 or
CX3CR1-deficient (gfp/gfp) mice (Fig. 1 D), indicating that
CX3CR1 is not essential for any step in the migration of
monocytes that become LN DCs. The majority of bead
cells in the LN were GFP. In the LNs, LX cells were
largely Gr-1lo, but most expressed the same level of GFP as
Gr-1int monocytes (Fig. 1, B and D). The half-life of GFP in
the positive cells is relatively long (15) and, therefore, can
serve for some time as a marker for cell lineage.
A few GFP LX cells were also present in the LNs
(Fig. 1 D, right). These may be derived from GFP precur-
sors, such as tissue macrophages, that engulfed beads in the
skin, but these were more likely derive from cells whose
integrity has become compromised during LN processing
because these cells had lower FSC-H than the GFP cells
and any of the original LX-bearing cells in the skin. Fur-
thermore, i.v. injection of clodronate liposomes was used
to deplete blood monocytes (5) without affecting skin mac-
rophages (unpublished data). This procedure resulted in an
87% average reduction in the number of bead monocyte-
derived DCs in the LNs (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20032152/DC1) and
correspondingly markedly diminished uptake of micro-
spheres in the skin. This result confirms that macrophages,
or any other tissue phagocyte, contribute marginally to the
microsphere-bearing cell pool in the LNs. Rather, mono-
cytes that derive either from Gr-1hi or Gr-1int subsets, but
apparently not from the Gr-1lo subset, are the major pre-
cursor. The GFP intensity of LN LX cells most closely
overlapped with the intensity of the Gr-1int population.
CCR2 Is Not Required for Trafficking Events That Precede
the Appearance of Phagocytic DCs in the LN: Quantitative Cor-
relation between the Number of Skin Gr-1int LX Monocytes and
the Number of LX Cells That Home to LNs. CCR2 is a
major CCR for inflammatory monocyte recruitment to in-
flamed sites (7, 8, 27). Its expression particularly character-
izes Gr-1hi monocytes (4) that were abundantly recruited to
Figure 1. Analysis of monocyte trafficking and microsphere transport
to LNs in CX3CR1gfp/gfp mice. (A) Monocyte subsets were identified in
blood of CX3CR1gfp/gfp mice as GFP cells with differing levels of Gr-1,
revealing the presence of a small Gr-1int subpopulation in addition to pre-
viously described Gr-1hi and Gr-1lo populations. (B) GFP fluorescent in-
tensities of these subsets, stable and noninterconverting for at least 1 d (4),
were compared with the fluorescent intensities of cells that engulfed red
fluorescent microspheres deposited in skin, examined 14 h after injection,
and in cells that emigrated from skin to LNs by day 2. The same settings
in flow cytometry were used to acquire all of these data, making them
directly comparable. (C) Profiles of the cells in skin at the site of micro-
sphere injection at 14 h are shown. (D) Quantification and profiles of
LX-bearing cells that migrated to LNs were analyzed at day 2. To com-
bine data from different experiments, the mean number of migrated cells
in WT mice was set equal to 1.0 for each experiment, and relative values
for all WT and knock-out individuals in that experiment were calculated.
Six mice were studied for each part of the figure over the course of two
experiments with three mice in each group.
Figure 2. Analysis of monocyte trafficking and microsphere transport
to LNs in CCR2 mice. (A) The relative distribution of the various
blood monocyte subsets was compared between CCR2 and CCR2
mice. (B) The relative proportions of Gr-1hi and Gr-1int phagocytes bear-
ing LX were also compared in the skin, 14 h after injection of green fluo-
rescent microspheres. (A and B) Bold line profiles identify CCR2
monocytes. and thin lines identify CCR2 monocytes. (C) The number
of DCs bearing two or more LX particles in the draining LNs was quantified
2 d later. The increased number of LX cells in CCR2 LNs was statis-
tically significant: P 	 0.04.
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engulf LX microspheres. Thus, we tested whether the ab-
sence of CCR2 affected migration of monocytes into skin
that would later differentiate into phagocytic, LN-hom-
ing DCs. First, we compared blood monocytes between
CCR2 and CCR2 mice. To examine monocytes in
blood, we stained mouse leukocytes to identify M-CSF
receptor (CD115) F4/80 monocytes with expected
FSC-H/SSC-H properties (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20032152/DC1) and
identified the three subsets with differential levels of Gr-1.
This cell surface phenotype was appropriate for defining
monocytes because this population was selectively reduced
in monocyte-deficient op/op mouse blood (unpublished
data). CCR2 mice showed a consistent and marked re-
duction in the frequency of Gr-1hi blood monocytes, ac-
companied by a more pronounced Gr-1int monocyte popu-
lation (Fig. 2 A). This was not likely due to impaired
development of Gr-1hi monocytes in these mice because
Gr-1hi monocytes appeared abundantly and initially were
the most numerous monocytes in CCR2 blood after
clodronate liposome treatment to transiently eliminate blood
monocytes (unpublished data), just as observed in WT
monocytes (5).
Next, we examined the profile of skin-infiltrating pha-
gocytes in CCR2 and CCR2 mice. We focused on
the period just after the plateau in their recruitment (12–
14 h), when the cells would be expected to most closely re-
semble their blood counterparts. As expected from the fact
that bead-bearing cells were mostly GFP in CX3CR1gfp
mice, the overwhelming majority of the phagocytes that
engulfed LX were F4/80 (unpublished data). They were
also largely comprised of Gr-1hi cells (Fig. 2 B), consistent
with observations of monocyte recruitment to sites of in-
flammation (4, 5). Gr-1int monocytes bearing beads were
also observed (Fig. 2 B), but Gr-1lo monocytes were absent.
These data agree with the profile of recruited monocytes in
CX3CR1gfp/gfp mice (Fig. 1 B). Gr-1hi cells were also ob-
served in CCR2 mice (Fig. 2 B), despite the fact that at-
tenuated numbers of Gr-1hi monocytes in blood persisted
even after injection of the LX beads in skin (not depicted).
In CCR2 mice, as in CCR2 mice, LX-bearing cells
also included Gr-1int monocytes (Fig. 2 B). These were rel-
atively few in CCR2 mice, but were two- to threefold
enriched in CCR2 mice (Fig. 2 B). The total yield of
LX-bearing skin cells was similar between CCR2 and
CCR2 preparations.
Our next step entailed quantifying the accumulation
of LX-bearing, monocyte-derived DCs in the LNs. The
number of these DCs was not reduced, but was unexpect-
edly nearly doubled in CCR2 mice (Fig. 2 C). This in-
crease in the number of migratory LX-bearing DCs in the
LN closely correlated with the increase in Gr-1int F4/80
cells in the skin, raising the possibility that Gr-1int mono-
cytes may be the more efficient precursors for DCs, com-
pared with Gr-1hi phagocytes. These data, together with
those from CX3CR1gfp/gfp mice, turned our attention to
Gr-1int monocytes.
Gr-1int Blood Monocytes Possess Allostimulatory Capacity,
Along with Gr-1lo Monocytes, and Selectively Express mRNA
for CCR7 and CCR8. In profiling blood monocytes, we
first noted that both Gr-1int and Gr-1lo monocytes possessed
higher costimulatory activity (Fig. 3 A) than Gr-1hi blood mono-
cytes. These data suggest that Gr-1int and Gr-1lo monocytes
resemble populations of human CD16 monocytes in their
increased expression of costimulatory activity after isolation
(6, 28), relative to more classical monocytes.
We analyzed mRNA from monocyte subsets for expres-
sion of CCRs. We stained F4/80 CD115 cells in WT
blood and sorted these cells into three populations: Gr-1hi,
Gr-1int, and Gr-1lo monocytes (Fig. S2). In addition to
conducting real-time PCR analysis for CCR2 and CX3-
CR1, we examined mRNA for the CCRs CCR7, a major
mediator of DC migration via lymphatics, and CCR8,
as we became interested in CCR8 after finding that
human CD16 monocytes expressed mRNA for CCR8
more significantly than did CD16 monocytes (Fig. S3,
available at http://www.jem.org/cgi/content/full/jem.
20032152/DC1). As expected, CCR2 mRNA was ex-
pressed in both Gr-1hi and Gr-1int monocytes, but reduced
in Gr-1lo monocytes (Fig. 3 B). CX3CR1 mRNA was
found in all populations (Fig. 3 B), also as expected, al-
though sorted Gr-1lo monocytes did not show the highest
levels of CX3CR1 mRNA (Fig. 3 B), which apparently
differs from protein levels (4). Strikingly, CCR7 and CCR8
mRNA were selectively expressed by Gr-1int monocytes
(Fig. 3 B).
CCR8 Regulates Emigration of Monocyte-derived DCs to
LNs without Acting Redundantly with a Role for CCR7
Ligands. Given these findings, we set out to determine
whether selective expression of CCR7 or CCR8 mRNA
by this population might relate to a role for these receptors
in migratory events that lead to the accumulation of mono-
cyte-derived DCs in LNs. Although CCR7 is known to be
a major regulator of DC migration, the role of this receptor
or its ligands in the migration of monocyte-derived, phago-
Figure 3. Analysis of monocyte subsets in blood: expression of costim-
ulatory activity and CCR mRNA. (A) Sorted Gr-1hi, Gr-1int, and Gr-1lo
subsets were irradiated and used as APCs in an MLR with BALB/c T
cells. This experiment is representative of two conducted experiments,
both showing similar results. (B) Real-time PCR for CCR2, CX3CR1,
CCR7, and CCR8 mRNA was conducted. Data are plotted as the per-
centage of expression relative to the subset with the highest expression of
a particular CCR. These data were repeated in a similar pattern in three
independent sorting experiments.
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cytic DCs is unknown. Thus, we tested whether the CCR7
or CCR8 pathways may be involved in the migration of
monocyte-derived DCs to LNs. Analysis of migration to
LNs in CCR8 mice revealed a 50% mean inhibition in
the accumulation of LX cells in LNs (Fig. 4 A). In contrast
with the findings in CCR2/ mice (Fig. 2), CCR8
mouse skin showed no alterations in phenotype of phago-
cytic cells, phagocyte yield, or distribution between Gr-1hi
and Gr-1int subsets (Fig. 4 A, inset) at any time point, indi-
cating normal recruitment of monocytes in CCR8 mice.
Accumulation of LX DCs in LNs was reduced by 90%
(Fig. 4 A) in plt/plt mice that lack several genes encoding
CCR7 ligands (29, 30) and that show greatly diminished
Langerhans cell recruitment to LNs (17). Thus, a role for
CCR8 in mediating accumulation of monocyte-derived
DCs in LNs does not replace a need for CCR7 ligands in
emigration, arguing that the two molecules function at dif-
ferent points in a common pathway downstream of recruit-
ment into skin. Although there were fewer phagocytic
DCs in the LNs of CCR8-deficient mice, the phenotype
of the emigrated cells that were there was similar to WT
mice. For example, these cells expressed very high levels of
MHC II (Fig. 4 B, top). We also noted that the LX cells
of WT mice were Gr-1lo in the LNs. In contrast, for up to
3 d in skin there were no MHC IIhi or Gr-1lo LX cells
present, only MHC IIint cells (Fig. 4 C and not depicted).
This pattern was also true in plt/plt mice (unpublished
data), suggesting against our expectations that failure to
emigrate to LNs does not lead to a build-up of mature LX
DCs in the skin. Thus, maturation may normally continue
or complete as the cells are en route to the LNs.
The expression of CCL1, the ligand for CCR8, in skin
(Fig. 4 D) revealed no apparent staining of LYVE-1 lym-
phatic capillaries (31), but other vessels, likely blood vessels,
were positive as expected (32). In LNs, CCL1 was ex-
pressed in the subcapsule of the LNs (Fig. 4 E) and was also
observed in paracortical vessels that are likely high endo-
thelial venules (Fig. 4 E, right). These data raise the possi-
bility that CCL1/CCR8 may function downstream of en-
try into lymphatics by regulating entry in the subcapsular
sinus of the LNs.
Gr-1int Monocytes More Readily Differentiate into Potent
APCs Than Gr-1hi Monocytes: Role for CCR8. We fo-
cused further on whether Gr-1int monocytes that were re-
cruited to tissues might be more efficient precursors for
DCs, compared with Gr-1hi monocytes. Gr-1int and Gr-1hi
monocytes are similarly recruited to the inflamed perito-
neum (5), as we observed in skin. Thus, we took advantage
Figure 4. Analysis of cell-mediated micro-
sphere transport to LNs in CCR8 and
plt/plt mice. (A) Green fluorescent LX micro-
spheres were injected into the skin of CCR8-
deficient mice and plt/plt mice that were
compared with age- and sex-matched WT
C57BL/6 counterparts. The number of
DCs bearing two or more LX particles in
the draining LNs was quantified 3 d later.
To combine data from different experi-
ments, the mean number of migrated cells
in WT mice was set equal to 1.0 for each
experiment, and relative values for all WT
and knock-out individuals in that experi-
ment were calculated. Inset shows Gr-1
staining intensity among gated bead cells
from CCR8 (bold line) and CCR8
mice (thin line) in the skin 14 h after bead
injection. (B and C) Plots show MHC II
(I-Ab) and Gr-1 levels in LNs and skin of
WT and CCR8 mice. LN plots (B) are
quantitative comparisons, as they depict the
entire population of LX-bearing cells re-
covered from pooled brachial LNs from in-
dividual mice. Skin plots (C) are not quanti-
tative comparisons. Where available, plots
depict all acquired events, although in some
experiments (for MHC II staining in LN),
LX cells were gated during acquisition to
reduce file size. (D) High power magnifica-
tion of WT skin section stained for LYVE-1
(green) and CCL1 (red). (E) LYVE-1
(green) and CCL1 (red) in LN subcapsular si-
nus (left, high power magnification). CCL1
staining in LN at low power (right). Outer
subcapsule is indicated by an arrow.
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of the ease of retrieving these cells from the peritoneum for
experiments that require greater cell yields. Sorted Gr-1int
and Gr-1hi monocytes that had recently migrated into the
peritoneal cavity after injection of thioglycollate were col-
lected and cultured in GM-CSF for 2 d, which led some
monocytes to acquire characteristics of DCs (17). Next, al-
lostimulatory activity was assessed. In some samples, neu-
tralizing mAbs to CCL1, the ligand of CCR8, or mAb to
CCL19, a ligand of CCR7, was included during the 2-d
GM-CSF treatment, but not added during the T cell stim-
ulation period. Differentiation was analyzed by allostimula-
tory activity because marker stainings were unreliable after
the initial three-color sorting of the two populations. Gr-
1int monocytes developed a much more robust allostimula-
tory capacity than Gr-1hi monocytes (Fig. 5). The capacity
to stimulate T cell proliferation by Gr-1int monocyte-
derived cells was partially blocked by anti-CCL1, but not
affected by anti-CCL19, which served as a control (Fig. 5).
Thus, these data support the earlier indications that Gr-1int
monocytes more efficiently become DCs and suggest that
signals via CCL1/CCR8 participate in this process.
CCR8 Mediates Reverse Transmigration of Human Mono-
cyte-derived DCs. A role for CCR8 in emigration of
monocyte-derived DCs to LNs has not been anticipated in
the literature because little is known about the role of this
CCR on phagocytes. Thus, we wondered whether CCR8
may also be relevant to the migration of human monocyte-
derived cells in the reverse transmigration model (21, 22)
that we have proposed involves analogous steps in migra-
tion as observed for monocyte-derived DCs in vivo.
CCR8 mRNA has been detected in freshly isolated, to-
tal human monocytes (33). When we tested for CCR8
mRNA in monocyte subsets, it was apparent that higher
levels of CCR8 mRNA were found in bulk CD16
monocytes, relative to CD16 monocytes (Fig. S3). Sur-
face protein levels were very low, even on CD16 mono-
cytes (unpublished data). During culture with endothelial
cells grown on collagen matrices, CCR8 mRNA and pro-
tein expression was induced in all monocyte-derived cells,
whether or not they joined the reverse-transmigrating pop-
ulation or remained in the subendothelium (Fig. 6 A and
not depicted). An additional analysis of the expression of
CCR8 by HLA-DR cells that migrated from human
Figure 5. Allostimulatory capacity of monocyte subsets sorted from the
periphery and effect of an antagonist to the CCR8 ligand CCL1. (A) Gr-1hi
and Gr-1int recruited monocytes from the peritoneal lavage of C57BL/6
CCR8 mice were sorted to purity by flow cytometry using mAbs to
F4/80 and Gr-1. The cells were cultured separately in GM-CSF for 2 d
in the absence of added mAb, or in the presence of 5 g/ml of neutraliz-
ing mAbs to chemokines CCL1 (TCA-3) or CCL19. These cells were
washed to remove residual antibodies and cultured with BALB/c T cells
for evaluation of their potential to support allogeneic T cell proliferation
in a mixed lymphocyte reaction. These data depict one out of two exper-
iments conducted with similar results.
Figure 6. Expression of CCR8 by human monocyte-
derived cells and skin DCs, and its role in reverse trans-
migration. Monocytes were cocultured with endothelial
cells grown on a type I collagen gel for 48 h, permitting
the separation of the population into reverse-transmigrat-
ing DCs (RT) or subendothelial macrophages (SE).
(A) Anti-CCR8 mAb 3B10 (thin solid line) reacted
with both RT and SE monocyte-derived cells. Isotype-
matched mAb was used to establish the baseline for
negative staining (dotted line). Anti-CCR8 mAb 3B10
specifically recognized an 54 kD band by immunoblot,
shown only for SE monocyte-derived cells (inset). (B)
CD14 DC precursors from human skin, but not CD14
DCs, were positive for CCR8 by immunoblot. Blotting
for -actin was conducted as a loading control. (C) Inclu-
sion of neutralizing anti-CCR8 mAb 3B10 during the
assay when monocytes traverse endothelium in the apical-
to-basal direction had no effect (left), but 3B10 anti-
CCR8 mAb and anti-CCR8 mAb 5B11 significantly
(P 	 0.005) inhibited reverse transmigration in more
than five independent experiments. (D) CD16 mono-
cytes were selected by magnetic depletion to remove
CD16 monocytes and cultured overnight in the pres-
ence or absence of TGF1 to induce CD16 (top). In
some samples, 20 ng/ml TGF1 was added together
with neutralizing mAbs to CCR1, CCR2, or CCR8.
Expression of CD16 was monitored by flow cytometry.
This result is representative of five experiments.
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skin explants revealed CCR8 protein associated with the
CD14 dermal precursors of DCs (26, 34), but not CD14
emigrated Langerhans cells (Fig. 6 B). In agreement with
the implication that CCR8 may selectively regulate traf-
ficking of monocyte-derived DCs, and not affect Langer-
hans cells, is the finding that, in CCR8 mice, Lan-
gerhans cell trafficking to LNs in response to contact
sensitizers is normal (unpublished data).
When we tested the effect of neutralizing CCR8 ac-
tivity, we observed that the initial migration of mono-
cytes across endothelium to enter the collagen gels was not
blocked by anti-CCR8 mAb (Fig. 6 C, left), suggesting
that CCR8 did not participate in recruitment of mono-
cytes. In contrast, the reverse transmigration of monocyte-
derived cells that accompanies DC differentiation was sig-
nificantly blocked by anti–human CCR8 mAbs (Fig. 6 C,
right). Thus, CCR8 is not required for recruitment of
monocytes, but participates importantly in the migratory
clearance of monocyte-derived DCs from tissues in hu-
mans, as it does in mice.
We examined how neutralizing CCR8 may affect mono-
cytes in the absence of endothelium. Anti-CCR8 mAb
interfered with conversion of monocytes from CD16
monocytes to CD16 monocytes. Specifically, CD16 can
be induced on monocytes by treatment with TGF1. This
induction was totally blocked by anti-CCR8 mAb, but not
by mAb to CCR1 or CCR2, as controls (Fig. 6 D). The
effect of anti-CCR8 in preventing CD16 expression was
not related to loss or down-regulation of CD16 after in-
duction because anti-CCR8 mAb did not change surface
levels of CD16 once induced (unpublished data). These
data point to a role for CCR8 in the transition between
human monocyte subsets.
Discussion
Monocyte Subsets: Differentiation and Trafficking. Two dis-
crete monocyte subsets have been described in both hu-
mans and mice (4). The difference in CCRs expressed in
these populations is one feature that suggests the subsets
may have different homing properties and likely distinct
functions. Often overlooked in the classification is the
presence of a third subset, relatively well characterized as
CD64CD14CD16 cells among human monocytes (6,
35), and only recently recognized in mouse monocytes as
Ly-6C Gr-1int cells (5).
Herein, we traced monocyte subsets and their usage of
CCRs in a model that involves minimal ex vivo culture or
manipulations such as adoptive transfer. In the assay used,
most monocytes differentiate into tissue macrophages,
whereas others simultaneously become DCs that home to
the T cell zone of draining LNs (1). Monocyte-derived
cells are traced through their acquisition of fluorescent par-
ticles (1), and if these particles are coupled to protein anti-
gens, LN particle-bearing cells present the antigen to T
cells (10). First, we asked whether either of the chemokine
pathways that distinguish the two major monocyte subsets
from each other (CCR2 and CX3CR1) are required to at-
tract monocytes to the site of particle deposition, in turn af-
fecting the appearance of monocyte-derived DCs in LNs.
Earlier work suggested that human CD16 monocytes
preferentially differentiate into migratory DCs. The equiv-
alents of these human CD16 monocytes are thought to be
the CCR2 CX3CR1Gr-1lo monocytes (4). Contrary to
our expectations, Gr-1lo monocytes (4) did not become
particle-bearing LN DCs in the assay. Indeed, no Gr-1lo
(GFPhi in CX3CR1gfp mice) monocytes were recruited to
the skin site. Instead, most particles were acquired by Gr-
1hi and Gr-1int monocytes, populations known to migrate
to sites of inflammation (4, 5). These subsets express CCR2
(4) and use CCR2 to emigrate to sites of inflammation
(7–9) and lung infection (13, 36), for example. However,
these monocyte subsets were unexpectedly still capable of
migration to the skin site of microsphere injection in the
absence of CCR2, suggesting usage of other CCRs and
possible redundancy among them in this particular context.
This result differs from other work in which migration of
antigen-bearing APCs to the LNs after intramuscular im-
munization was remarkably reduced in CCR2 mice
(11). Differences may be technical because we did not pu-
rify different LN populations before analysis, or the major
difference could be in the model studied. The present
model is minimally inflammatory and, therefore, may
involve different CCRs during monocyte recruitment.
Moreover, the assay used herein explicitly focuses on
monocyte-derived DCs, which appear to migrate more
readily to LNs in the absence rather than the presence of
microbial stimuli (10), giving rise to the possibility that the
cells we trace participate in a more regulatory role in im-
munity. In an earlier paper (11), it is possible that the mi-
grating population did not derive from monocytes, but
could rather arise from other DC precursors that use
CCR2 in steps upstream of emigration to LNs, including
Langerhans cells and their precursors (12, 14).
During our study of different knockout and knockin
strains of mice, several points suggested that, between re-
cruited Gr-1hi and Gr-1int monocytes, the latter may be
more likely to give rise to LN DCs. First, shifts in the pro-
portion of Gr-1int monocytes in the skin correlated with
the magnitude of LX cells in LNs. That is, Gr-1int mono-
cytes were more numerous in the skin of CCR2 mice,
and the number of LX bead monocyte-derived DCs was
surprisingly and correspondingly increased in the LN of
CCR2 mice. Indeed, the fraction of Gr-1int monocytes
in the total LX monocyte pool agrees with the relative
fraction of monocytes earlier predicted to become DCs
(1). Second, the GFP intensity of LN DCs bearing mi-
crospheres overlapped closely with Gr-1int monocytes in
CX3CR1gfp/gfp mice. Furthermore, expression of CCR7
and CCR8 mRNA particularly characterized Gr-1int mono-
cytes, and we observed that CCR7 and CCR8 regu-
lates accumulation of LX-bearing DCs in the LNs. Finally,
in culture, Gr-1int but not Gr-1hi monocytes more readily
acquired APC function during the same interval of time
that the migration assay from skin to LN takes places (2-d
migration and 2-d culture in GM-CSF). Therefore, it ap-
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pears that Gr-1int monocytes are the best candidates among
monocytes to give rise to lymphatic trafficking DCs.
An argument can be made that Gr-1hi monocytes are the
precursors for Gr-1int monocytes, which in turn are the
precursors for Gr-1lo monocytes (5). If so, what concern
should there be over tracing the fate of Gr-1hi versus Gr-
1int monocytes because Gr-1hi monocytes may eventually
trickle down the lineage and differentiate into and along
the same paths as Gr-1int monocytes? Once a monocyte
leaves the bloodstream, the cues that it receives from the
endothelium through which it traverses, from the matrix
through which it migrates, and from the cells and mole-
cules in environment, strongly influence its maturation.
Even if a relatively immature monocyte (Gr-1hi) will be-
come a Gr-1int monocyte in the blood, how far that mono-
cyte has differentiated in the blood by the time of diape-
desis may affect how it responds to the environment and
whether it is diverted to a macrophage or DC. At certain
points in differentiation, a monocyte may be more suscep-
tible to receive cues that will direct a migratory DC pheno-
type. It is interesting in that regard to consider our finding
that Gr-1int monocytes, in contrast with Gr-1hi and Gr-1lo
monocytes, selectively expressed mRNA for CCR7 and
CCR8. This result shows that Gr-1int monocytes are more
than a cell type midway between the two other subsets, but
indeed express distinctive identifiers. The presence of these
CCR mRNAs may signify, along with possibly other un-
known characteristics, a transient readiness or preparation
to receive particular signals for differentiation or migration.
Role of CCR8 in Monocyte-derived DC Differentiation and
Migration to the LNs. Little is known about CCR8, the
CCR for CCL1 (TCA-3 in mouse, I-309 in human; refer-
ence 37), in the biology of DCs. It is well known to be ex-
pressed by eosinophils and particular populations of T cells,
including Th2 cells, regulatory T cells, and skin-homing T
cells (38–40). CCR8 is also expressed by monocytes (33),
NK cells (41), and nonhematopoietic cells including endo-
thelial cells (23) and smooth muscle cells (24). Phagocyti-
cally active macrophages in the CNS up-regulate CCR8
(42), and the production of CCL1 in the early stage of in-
flammation in experimental allergic encephalitis is a pivotal
mediator in the magnitude of inflammation observed (43).
CCR8 mice show delayed inflammation in this model
(43). Studies in CCR8 mice reveal that it may mediate
Th2 responses (16), whereas others report no obvious de-
fect in immunologic priming to soluble antigens adminis-
tered in potent adjuvant solutions (44, 45). Our studies, as
well as aforementioned others, suggest that the immune
response to particulates may be more affected than to solu-
ble antigens because monocyte-derived DCs are probably
APCs for the presentation of particulate, but not soluble
antigen (1, 10). Alternately, because we observe only a par-
tial block in migration of monocyte-derived DCs in the
absence of CCR8, a major effect on immunity may not be
observed even when presentation is restricted to mono-
cyte-derived DCs.
Antigen-presenting DCs have not been characterized
with regard to CCR8 expression, but recent evidence sug-
gests that they induce CCL1 mRNA in response to micro-
bial inflammatory stimuli such as schistosomal egg infection
(46). In another work, human monocyte-derived DCs, but
not macrophages, expressed mRNA for CCL1 (35) and,
interestingly, the most mature CD16 monocyte subset
(CCR2) was the only of the three human monocyte sub-
sets that also expressed CCL1 (35). In these past stud-
ies, functions for CCL1 and CCR8 were completely un-
known. Our data begin to shed some light on roles for
CCR8 in regulating monocytes, macrophages, and DC bi-
ology. Finding of a novel role for CCR8 in affecting access
of monocyte-derived DCs to LNs provides new informa-
tion that might help to explain why some micro-organisms
target the function of CCR8 or CCL1 (47–49).
We observed fewer LX monocyte-derived DCs in the
LNs of CCR8 mice compared with WT mice. CCR8
was not required for monocyte recruitment to skin because
the number and phenotype (Gr-1hi and Gr-1int) of phago-
cytic monocytes in the skin were similar, suggesting that it
more likely affects mobilization from skin to LNs. How-
ever, CCL1/CCR8 probably does not function to attract
phagocytic DCs to lymphatics because CCR7 ligands fulfill
this role and because CCL1 was not obviously expressed by
lymphatic vessels, consistent with data from human skin
(32). Instead, CCL1 was observed in the LN subcapsule. It
is not known whether emigration of cells into the LN via
afferent lymphatics requires chemokine signals to specifi-
cally enter the subcapsular sinus. If so, CCL1 is positioned
to play a role at this point of entry, thereby possibly ex-
plaining the reduced numbers of LX cells in CCR8
mice. In vitro differentiation studies in both human and
mouse cultures additionally, or alternatively, suggest that
CCR8 and its ligand CCL1 may participate in differentia-
tion of monocytes to DCs. CCR8 may even participate in
the transition of monocytes from one subset to another.
However, full differentiation to mature DCs may not be a
prerequisite for migration into LNs via lymphatics, as our
data indicate that some stages of maturation to DCs occur
while the cells are in transit to the LN or after their arrival.
In some settings, CCL1 and CCR8 regulate survival (50–
52), raising the possibility that differential survival, not
migration, accounts for the decreased the number of phago-
cytically labeled DCs in CCR8 LNs. However, this pos-
sibility is inconsistent with our studies using human mono-
cytes in a model of transendothelial trafficking, where we
can evaluate both the migratory and sessile fraction of cells
quantitatively. In this model, fewer reverse-transmigrating
cells corresponded with increased numbers of monocyte-
derived cells in the subendothelium. Furthermore, in the
LX bead assay, death of phagocytes in the LN results in pas-
sage of the microspheres to other cells (unpublished data), so
that the original number of migrated cells can be traced for
up to 10 d, even after apoptosis of input DCs.
In summary, this work begins to unravel the role of
CCRs in the migration of monocytes that ultimately de-
velop into lymphatic trafficking DCs. The findings confirm
some expected results, such as the role of the CCR7 path-
way in migration of monocyte-derived DCs to LNs; bring
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us some surprises like the lack of a role for CCR2 and
CX3CR1 in the generation of these migratory LN DCs;
and reveal a novel role for the CCR CCR8 in migration of
monocyte-derived DCs via lymphatics.
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